Related Experiment Video
Updated: Sep 18, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas
Nathan D Seligson1,2, Anjali Paragji1, Feha Shahalam1
1Department of Pharmacotherapy and Translational Research, The University of Florida, Jacksonville, FL, USA.
Abstract:
CIC::DUX4 translocation-positive sarcomas (CDS) are rare, highly proliferative tumors associated with chemotherapy resistance. Without a clear understanding of the molecular pathways driving CDS, no effective treatment regimens have been developed. Here, we identify protection against DNA damage through upregulation of POLE and DNA repair pathways specific to CDS. These data may explain the high proliferation rate and chemotherapy resistance of these tumors and suggest targeted treatment strategies for CDS.
Insights
CIC::DUX4 translocation-positive sarcomas (CDS) resist chemotherapy due to enhanced DNA repair. Upregulation of POLE and DNA repair pathways in CDS tumors explains their high proliferation and resistance, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- CIC::DUX4 translocation-positive sarcomas (CDS) are rare, aggressive tumors.
- These sarcomas exhibit high proliferation and resistance to chemotherapy.
- The underlying molecular mechanisms driving CDS remain poorly understood.
Purpose of the Study:
- To investigate the molecular pathways contributing to the aggressive phenotype of CDS.
- To identify specific mechanisms responsible for chemotherapy resistance in CDS.
- To uncover potential therapeutic targets for CDS treatment.
Main Methods:
- Analysis of molecular pathways in CDS tumors.
- Investigation of DNA damage response mechanisms.
- Assessment of POLE and DNA repair pathway activity.
Main Results:
- CDS tumors exhibit specific upregulation of POLE.
- Enhanced DNA repair pathways are identified in CDS.
- These pathways contribute to protection against DNA damage.
Conclusions:
- Upregulated POLE and DNA repair pathways contribute to the high proliferation and chemotherapy resistance in CDS.
- These findings provide a molecular basis for the aggressive nature of CDS.
- Targeting these specific pathways offers a promising strategy for future CDS treatments.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Positive Regulator Molecules
Inhibition of Cdk Activity
Epigenetic Regulation
X-chromosome...

